Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New PARP-1 inhibitor JI-1260 is a candidate for stroke therapy

June 8, 2011

VTX-2337 exhibits safety/tolerability in phase I trial in advanced solid tumors

June 8, 2011

BAY-80-6946 is well tolerated in first-in-human trial in advanced solid tumors

June 8, 2011

Sunitinib has limited efficacy in advanced adrenocortical carcinoma in phase II trial

June 8, 2011

New phase IIa data presented on sifalimumab in systemic lupus erythematosus

June 8, 2011

Liraglutide added to insulin shows promise in treating type 1 diabetes

June 7, 2011

Abagovomab does not prolong survival of patients with ovarian cancer in MIMOSA trial

June 7, 2011

First-in-human phase 0/Ia SM-101 study in healthy volunteers completed

June 7, 2011

Interim first-in-human data suggest MK-1496 is active against solid tumors

June 7, 2011

Theophylline improves motor function after stroke

June 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...